Considerations Regarding Recently FDA-Approved Agents for Chronic Spontaneous Urticaria
expert roundtables By Thomas B. Casale, MD; Allen P. Kaplan, MD; Giselle S. Mosnaim, MD, MS
The Impact of Diet and Obesity on Plaque Psoriasis Severity
patient care perspectives By Adam Friedman, MD, FAAD
Latest In Conference Reporter
Extending Overall Survival in HR+/HER2- Advanced Breast Cancer
conference reporter
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP, FASCO
Multigene Assays and the Management of HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Melinda L. Telli, MD, FASCO
Managing Endocrine Therapy–Related Side Effects and Adherence in HR+/HER2- Early-Stage Breast Cancer
conference reporter
By Virginia Kaklamani, MD, DSc; Ian Krop, MD, PhD; Melinda L. Telli, MD, FASCO
Conference Reporter® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics Being Presented at SABCS 2026
conference reporter
Advertisement